retatrutide osteoarthritis 5 medical breakthroughs this week (🧵) 1. Record-breaking 26.6% weight loss (placebo-adjusted, efficacy estimand) in its first phase 3 trial – and an improvement to knee https://t.co/aIK2cPQWHZ Lilly's triple agonist, retatrutide, drove

Among the plethora of novel agents against diabetes, GLP-1RAs are known to exert various biological effects in extra-pancreatic tissues beyond controlling hyperglycemia ( via central mechanisms ( Similarly, SGLT-2is, also referred to as gliflozins, represent another class of anti-hyperglycemic agents currently used in T2D treatment with favorable effects on body weight

Prescriptions were filled with an average turnaround time of 2.2 days, and 95.5% of approved medications were filled in a timely manner to help adherence

The real question is whether Sanofi focuses the asset where the data supports it, or whether the dermatitis miss casts too long a shadow over the program

Reduce to a lower dose

doi: 10.1016/j.jaut.2025.103453